The global at home blood collection market is expected to reach USD 747 million in 2021 anticipated to grow at a CAGR of 10.7% during the forecast period 2021-2035.

Since the onset of the COVID-19 pandemic, there has been a noticeable decline in patient visits to laboratories for sample collection and testing, largely due to concerns about potential infection risks. This decrease has been substantial, with laboratories globally reporting an average reduction of about 40% in phlebotomy appointments. This shift in behavior led to a growing interest in the development of innovative devices and technologies, enabling individuals to collect blood samples at home for remote health monitoring.
More than 80% of the self-blood collecting devices surveyed have received marketing approval, highlighting a significant progression in this area. Notably, in 2021, both the TAP? II and Tasso-M20 self-blood collecting devices obtained the CE mark from the European Commission. Additionally, Symbiotica recently obtained emergency use authorization from the USFDA for its at-home COVID-19 serology test kit, capable of detecting SARS-CoV-2 using dried blood spot samples.
The market for at-home blood collection and micro-sampling devices exhibits a diverse landscape, encompassing start-ups, small companies, and mid-sized firms. An intriguing revelation is that more than 40% of the start-ups in this market emerged since 2014, signifying a recent surge in entrepreneurial activity. Notably, larger companies are strategically acquiring smaller players to either bolster their capabilities or venture into this specialized sector. Consequently, this trend has led to a substantial rise in partnership activities within the domain of at-home blood collection devices. Financially, investors?both public and private?have injected over USD 640 million into this market since 2014.
With the increasing inclination towards self-blood collection and home-based sampling methods, combined with ongoing endeavors by developers and manufacturers to expand their product offerings, it is anticipated that the market for at-home blood collection and micro-sampling devices will witness significant growth in the forthcoming forecast period.

Report Coverage
? The primary research insights into an executive summary, offering a high-level overview of the at-home blood collection and micro sampling devices market, including its near-term and long-term evolution.
? Introduction of at-home blood collection and micro sampling devices, covering various applications, blood sampling types, collection methods, devices used, and associated benefits.
? Detailed market landscape analysis, encompassing device classifications, development statuses, regulatory approvals, technologies, usage types, sample specifics, companies involved, and more.
? A thorough competitive analysis of these devices based on supplier expertise and product specifications.
? A comprehensive profile of key industry players, detailing their backgrounds, headquarters, workforce, executives, product portfolios, recent activities, and future prospects.
? Analysis of patents filed/granted since 2015 within this domain, exploring parameters like patent types, publication years, applicability, focus areas, active players, and patent valuation.
? Recent partnerships between industry players, examining partnership models, focus areas, therapeutic domains, and regional distributions from 2014 to 2021.
? A detailed breakdown of investments in this domain, analyzing parameters such as funding instances, amounts invested, funding types, active players, investors, geographical distribution, purposes, and application areas.
? The potential cost savings associated with at-home blood collection and micro sampling devices based on various pertinent factors.
? A market forecast analysis, segmenting the market by blood sample state, sample collection method, device usage, application areas, and geographical regions until 2035.
? A comprehensive summary, consolidating all the key facts and figures from previous chapters, while also spotlighting evolutionary trends shaping the future of this market.

Key Market Companies
? EUROIMMUN
? Everlywell
? Labcorp
? Labonovum
? Lameditech
? Quest Diagnostics
? Spot On Sciences
? Tasso
? Weavr Health
? YourBio Health